Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. - Wikidata - wikimedia - TriplyDB

Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy.

Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy.

http://www.wikidata.org/entity/Q34620919

about

Transarterial radioembolization for hepatocellular carcinoma: a review Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review Side effects of yttrium-90 radioembolization Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives Temporary arterial balloon occlusion as an adjunct to Yttrium-90 radioembolization.Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Usefulness of Bremsstrahlung Images after Intra-arterial Y-90 Resin Microphere Radioembolization for Hepatic Tumors.Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (¹³¹I-GMSs) following intratumoral injection.Chemoembolization and radioembolization for metastatic disease to the liver: available data and future studies.Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with 90Y microspheres Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization Prophylactic embolization of the cystic artery before radioembolization: feasibility, safety, and outcomes.Research reporting standards for radioembolization of hepatic malignancies.Technical solutions to ensure safe yttrium-90 radioembolization in patients with initial extrahepatic deposition of (99m)technetium-albumin macroaggregates Radioembolization for primary and metastatic liver cancer.Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignancies Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs.Yttrium-90 microsphere induced gastrointestinal tract ulceration Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials.Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases.Techniques of interventional tumor therapy.Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomes A serious complication of selected internal radiation therapy: case report and literature review Root cause analysis of gastroduodenal ulceration after yttrium-90 radioembolization.Intra-arterial therapies for metastatic colorectal cancer.Advances in managing hepatocellular carcinoma.Liver-directed therapies in metastatic colorectal cancer.Skin Necrosis Resulting from Nontarget Embolization of the Falciform Artery during Transarterial Chemoembolization with Drug-Eluting Beads.Gastric injury from (90)Y to left hepatic lobe tumors adjacent to the stomach: fact or fiction?Hepatic radioembolization complicated by gastrointestinal ulceration.Medication-associated gastrointestinal tract injury.Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases.Selective internal radiotherapy (SIRT) of hepatic tumors: how to deal with the cystic artery.N-butyl cyanoacrylate glue embolization of arterial networks to facilitate hepatic arterial skeletonization before radioembolization.Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: incidence and predisposing technical factors in 142 patients.Safety of repeated yttrium-90 radioembolization.Standards of practice in transarterial radioembolization.Downstream hepatic arterial blood pressure changes caused by deployment of the surefire antireflux expandable tip.

P2860

Q26738273-D9A0F400-6FF1-4CC2-9836-1332153E3C29 Q26743603-2EC4AE20-3EEA-487F-B08F-A172B6425B67 Q26821887-F808E8DA-C9F4-426E-9072-E806A159394F Q26852174-0E03304C-5FFF-44FC-AC36-04950B9822FC Q28081783-0593EFC0-8EBD-40B7-9874-FEDFC3DFB986 Q30456316-F252E580-8114-443C-8297-85A4A471257B Q30468280-41C5A22D-EAFD-4E80-A678-290B3FD8A9B0 Q33704156-51C29E2B-D474-4ACA-8501-AB2BE62907DE Q33851393-3CC0CE7D-2F2D-4638-85EA-3828422C1EF5 Q34330617-8F0D3284-56E2-4B87-8BE2-7EB3D87E32D0 Q34339631-B9E53035-683A-49AF-B9A4-498318F52482 Q34584472-6EFDD766-43AA-4FB9-A66E-42D7F68897FB Q35094057-EF4503DB-A3EB-4526-8493-01528608C11C Q35111887-B8A74B3D-7587-49FA-93DF-EBE07FDDA8A6 Q35206768-7EAE460D-7B49-4151-A0A2-80B0973EF42E Q35564038-9459A00C-3C7C-425C-B061-4F1A308A2AA0 Q36656612-FDA0596B-FED5-40FB-9029-26647F678A26 Q36738344-69E020A6-A346-4203-9518-06155E5A57A1 Q36871389-219495B7-986B-4B72-B94D-863D933CE406 Q37113543-E3C35117-CA4D-4184-9DC7-93E0BEDB3E7A Q37124697-C3680328-5072-40C0-9221-0CD1FDBFC40D Q37392026-6564DBBE-B0F6-4B97-A9AE-E429CD4C18FF Q37496689-50E9085D-8E8C-480D-BA9D-85C85E6B10C9 Q37669068-E1878330-EB6A-4C1C-830F-07B00B19DFAF Q37778639-0CDB4A91-BED2-4224-9521-5DAD21ACFDD6 Q38084139-6508DF0C-A23D-4F2F-8715-D5E60BFFD8AB Q38179343-FD2B5AA9-266A-4404-9ED7-F095F59D5E32 Q38210345-C8CEC111-EC2A-4F15-8044-C5469858761C Q38256165-5BE99DCD-879D-443F-A9CA-A76641CD9604 Q38374665-410D683A-437B-4216-A287-02A74FA6FAFD Q38551055-40CD446A-0449-400B-BB51-07C9F4DFA70D Q38704940-9D012B07-0251-4CF0-90E0-9190A94D51EA Q39108620-30B3A509-2793-4AE8-880F-3C0647E3A300 Q39761939-D3B0D394-7251-4F41-A425-CFDC4D5E6801 Q40063283-7BC4B477-7F2B-4051-8727-FA897B7BDA2C Q40069160-55BA1697-6B77-4D72-BD54-27B38274A4DA Q40101262-63682B74-93C2-4751-87CE-9215AB9D9699 Q44200845-64BBAF34-42A1-437A-9A5B-BB89440BF81C Q45128821-CAD3EA1D-B6FE-4378-9288-E790731AC5EC Q45652073-D0E5EA3A-C6F9-4B42-A835-457D4FE6B994

P2860

Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy.

http://www.wikidata.org/entity/Q34620919

description

2007 nî lūn-bûn

@nan

2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Gastrointestinal complications ...... ttrium-90 microsphere therapy.

@ast

Gastrointestinal complications ...... ttrium-90 microsphere therapy.

@en

Gastrointestinal complications ...... ttrium-90 microsphere therapy.

@nl

type

label

Gastrointestinal complications ...... ttrium-90 microsphere therapy.

@ast

Gastrointestinal complications ...... ttrium-90 microsphere therapy.

@en

Gastrointestinal complications ...... ttrium-90 microsphere therapy.

@nl

prefLabel

Gastrointestinal complications ...... ttrium-90 microsphere therapy.

@ast

Gastrointestinal complications ...... ttrium-90 microsphere therapy.

@en

Gastrointestinal complications ...... ttrium-90 microsphere therapy.

@nl

P1433

Q34620919-3D0D8A41-2B2D-460D-822C-C66982684F51

P1476

Q34620919-BA446783-D0DC-48A0-B7EA-281FBA79ECFF

P2093

Q34620919-11E6FFFC-9F0B-40BC-8A25-9FA1A0AA08CC

Q34620919-2FF79FAE-A9D1-40FD-B425-120B54F65CD7

Q34620919-3CC2B7EC-92E8-4E57-A794-69EAB5D4EBEB

Q34620919-3E66E943-6C74-4415-B4A9-E64A78038D09

Q34620919-873EBD80-2BC4-440A-8268-37433659395C

Q34620919-8F33A25F-4F64-4F98-A0B1-C090DB4AFD99

Q34620919-9DD62C5E-8AC9-40E2-BCF8-EECB97AA4046

Q34620919-9DFB624C-BF1A-4C41-9139-95C7731CB0B1

Q34620919-B73DB5FF-1945-46A2-8511-7FF54A420005

Q34620919-C2955423-A63F-422A-B999-8DB1727BAEE3

P304

Q34620919-E5A8FB50-ECF9-4FD6-8309-3EB3DBF0B2D8

P31

Q34620919-2CD06143-A01E-476A-9E9E-9146197611A3

P356

Q34620919-F203B286-383D-4716-80B2-BC28601F4C0F

P433

Q34620919-7326C912-6633-419C-A414-E4B9F611CCA3

P478

Q34620919-13B07F7C-B09A-40EF-86E8-57B77A9A523B

P50

Q34620919-83E2C0E4-40C4-4915-8362-CF96A92FE314

P577

Q34620919-F0261A40-FF16-4754-817E-4C4BB785A8AC

P698

Q34620919-E298B346-4805-4ECC-850B-ACEE3E2E0F0F

P921

Q34620919-2FB95266-0A41-41C4-BE50-1E13E413436A

P356

J.JVIR.2007.02.002

P1433

Journal of Vascular and Interventional Radiology

P1476

Gastrointestinal complications ...... Yttrium-90 microsphere therapy

@en

P2093

Alan M Cohen

http://www.w3.org/2001/XMLSchema#string

Amit Habbu

http://www.w3.org/2001/XMLSchema#string

Daniel B Brown

http://www.w3.org/2001/XMLSchema#string

David Liu

http://www.w3.org/2001/XMLSchema#string

Douglas M Coldwell

http://www.w3.org/2001/XMLSchema#string

Michael Censullo

http://www.w3.org/2001/XMLSchema#string

Ravi Murthy

http://www.w3.org/2001/XMLSchema#string

Rodolfo Nunez

http://www.w3.org/2001/XMLSchema#string

Steven G Meranze

http://www.w3.org/2001/XMLSchema#string

Sunil Krishnan

http://www.w3.org/2001/XMLSchema#string

P304

553-61; quiz 562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JVIR.2007.02.002

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17446547

http://www.w3.org/2001/XMLSchema#string

P921